Scandinavian Real Heart AB (7820) Stock Price & Analysis

7820 Stock Chart & Stats

€1.38-€0.02(-1.43%)

At close: Oct 30 5:30 PM GMT+1

Day’s Range: EUR 1.38 - EUR 1.40
52-Week Range: EUR 1.10 - EUR 2.33
Previous Close: EUR 1.40
Volume: 0
Average Volume (3M): 0
Market Cap: EUR 12.97M
Enterprise Value: EUR 151.30M
Total Cash (Recent Filing): EUR 27.94M
Total Debt (Recent Filing): EUR 5.40M
Price to Earnings (P/E): ―
Beta: 0.03
Next Earnings: Nov 12, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Modest Leverage

Low leverage provides some financial flexibility because relatively limited debt reduces fixed repayment pressure and interest-related strain. This may help the company direct available funding toward development and regulatory work, although continued losses could still weaken that flexibility over time.

Critical-Need Product

The Realheart TAH addresses severe heart failure, a serious condition where transplantation and mechanical support are important treatment options. A product serving this high-need area could have meaningful clinical relevance and a differentiated role if development and validation ultimately support commercialization.

Focused Development Program

A focused program covering validation, regulatory preparation, and commercialization planning shows that development is directed toward advancing one core medical-device platform. Progress across these stages could build the evidence and approvals needed to convert the technology into a durable commercial opportunity.

Bears Say

Pre-Revenue Profile

The company has not yet demonstrated a stable commercial revenue stream, leaving its business model dependent on future product approval, adoption, and commercialization. Until that transition occurs, operating performance cannot be supported by recurring sales or established customer demand.

Persistent Cash Burn

Sustained negative operating and free cash flow indicates that the company is not self-funding its activities and must continue financing development from external sources. Ongoing burn can reduce financial flexibility and make progress toward commercialization more dependent on successful future funding.

Shrinking Equity Base

The declining equity base reflects the cumulative effect of continuing losses and cash consumption, reducing the financial cushion available to support development. If losses persist, the company faces the stated risk of further value dilution as additional financing may be required.

7820 FAQ

What was Scandinavian Real Heart AB’s price range in the past 12 months?

Scandinavian Real Heart AB lowest stock price was €1.10 and its highest was €2.33 in the past 12 months.

What is Scandinavian Real Heart AB’s market cap?

Scandinavian Real Heart AB’s market cap is €12.97M.

When is Scandinavian Real Heart AB’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Scandinavian Real Heart AB’s earnings last quarter?

Scandinavian Real Heart AB released its earnings results on Aug 26, 2026. The company reported -€0.253 earnings per share for the quarter.

Is Scandinavian Real Heart AB overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Scandinavian Real Heart AB pay dividends?

Scandinavian Real Heart AB does not currently pay dividends.

What is Scandinavian Real Heart AB’s EPS estimate?

Scandinavian Real Heart AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Scandinavian Real Heart AB have?

Scandinavian Real Heart AB has 8,497,797 shares outstanding.

What happened to Scandinavian Real Heart AB’s price movement after its last earnings report?

Scandinavian Real Heart AB reported an EPS of -€0.253 in its last earnings report. Following the earnings report the stock price went up 0.629%.

Which hedge fund is a major shareholder of Scandinavian Real Heart AB?

Currently, no hedge funds are holding shares in DE:7820

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description